National Aeronautics and Space Administration November 2005 – Federal Register Recent Federal Regulation Documents

The Civilian Agency Acquisition Council and the Defense Acquisition Regulations Council (Councils) have extended the due date by two weeks for public comments on their proposed rule that would amend the Federal Acquisition Regulation (FAR) to implement section 1432 of the National Defense Authorization Act for Fiscal Year 2004. Title XIV of the Act, referred to as the Services Acquisition Reform Act of 2003 (SARA), amended section 8002(d) of the Federal Acquisition Streamlining Act of 1994 (FASA) to expressly authorize the use of time- and-materials (T&M) and labor-hour (LH) contracts for certain categories of commercial services under specified conditions. The proposed rule was published in the Federal Register at 70 FR 56318, September 26, 2005.

Under the provisions of the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35), the Federal Acquisition Regulation (FAR) Secretariat has submitted to the Office of Management and Budget (OMB) a request to review and approve an extension of a currently approved information collection requirement concerning Federal acquisition and community right-to-know. A request for public comments was published in the Federal Register at 70 FR 54035, September 13, 2005. No comments were received. Public comments are particularly invited on: Whether this collection of information is necessary for the proper performance of functions of the FAR, and whether it will have practical utility; whether our estimate of the public burden of this collection of information is accurate, and based on valid assumptions and methodology; ways to enhance the quality, utility, and clarity of the information to be collected; and ways in which we can minimize the burden of the collection of information on those who are to respond, through the use of appropriate technological collection techniques or other forms of information technology.

The National Aeronautics and Space Administration, as part of its continuing effort to reduce paperwork and respondent burden, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995 (Pub. L. 104-13, 44 U.S.C. 3506(c)(2)(A)).

In accordance with the Federal Advisory Committee Act, Public Law 92-463, as amended, the National Aeronautics and Space Administration announces a meeting of the NASA Advisory Council.

This notice is issued in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant a partially exclusive license in the United States to practice the inventions described and claimed in U.S. Patent Nos. 5,153,131, entitled ``High Aspect Reactor Vessel and Method of Use''; 5,153,132, entitled ``Three-Dimensional Co-culture Process''; 5,153,133, entitled ``Method for Culturing Mammalian Cells in a Horizontally Rotated Bioreactor''; 5,155,034, entitled ``Three Dimensional Cell to Tissue Assembly Process''; 5,155,035, entitled `` Method for Culturing Mammalian Cells in a Perfused Bioreactor''; 5,308,764, entitled ``Multi-Cellular Three-Dimensional Living Mammalian Tissue''; 5,496,722, entitled ``Method for Producing Non-neoplastic, Three- dimensional, Mammalian Tissue and Cell Aggregates under Microgravity Culture Conditions and the Products Produced Therefrom''; 5,627,021, entitled ``Three- Dimensional Co-Culture Process''; 5,637,477, entitled ``Recombinant Protein Production and Insect Cell Culture and Process''; 5,846,807, entitled ``Media Compositions for Three-dimensional Mammalian Tissue Grown under Microgravity Culture Conditions''; 5,851,816, entitled ``Cultured High-Fidelity Three-Dimensional Human Urogenital Tract Carcinomas and Process''; 5,858,783, entitled ``Production of Normal Mammalian Organ Culture Using a Medium Containing MEM-alpha, Leibovitz L-15, Glucose Galactose Fructose''; 5,962,324, entitled ``Three Dimensional Optic Tissue Culture and Process''; 6,177,674, entitled ``Pathogen Propagation in Cultured Three-Dimensional Tissue Mass''; 6,485,963, entitled ``Growth Stimulation of Biological Cells and Tissue by Electromagnetic Fields and Uses Thereof'', 6,673,597, entitled ``Growth Stimulation of Biological Cells and Tissue by Electromagnetic Fields and Uses Thereof''; 6,730,498, entitled ``Production of Functional Proteins: Balance of Shear Stress and Gravity''; 6,946,246, entitled ``Production of Functional Proteins: Balance of Shear Stress and Gravity'', and U.S. Patent Application Serial Number 10/734,759, entitled ``Production of Functional Proteins: Balance of Shear Stress and Gravity'', U.S. Patent Application Serial Number 10/947,786, entitled ``Production of Functional Proteins: Balance of Shear Stress and Gravity'', to Renautus Bio Therapeutics, LLC, having its principal place of business in Baton Rouge, LA. The patent rights in the inventions have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective partially exclusive license will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.